Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about TAK

Recent news which mentions TAK

< Previous 1 2 3 4 5 6 7 Next >
AC Immune's Active Immunotherapy Shows Antibody Responses In Early Parkinson's Patients
Tickers ACIU NEWS TAK
Tags Biotech Health Care Market News
From Benzinga
Urgency, Debate Mark COP29 As Leaders Push For Carbon Market Rules, Worry About Trump
Tickers F FAN ICLN NEWS
Tags SHEL Market News TAN
From Benzinga
Preview: Takeda Pharmaceutical's Earnings
Tickers TAK
Tags Earnings Market News BZI/EP
From Benzinga
Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside
Tickers ALMS BMY NEWS TAK
Tags BMY Health Care Biotech
From Benzinga
Johnson & Johnson Ends Phase 2 Study For Dengue Antiviral Amid R&D Reprioritization
Tickers JNJ NEWS TAK
Tags Stories That Matter JNJ Market News
From Benzinga
Protagonist Therapeutics' Two Investigational Candidates Target Over $10B Market, Bullish Analyst Opines
Tickers JNJ NEWS PTGX TAK
Tags Biotech Health Care Analyst Ratings
From Benzinga
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
Tickers AZN BMY ELVN NEWS
Tags TAK PFE Benzinga
From Benzinga
Shortage Relief: More Takeda's Vyvanse For ADHD On the Way As US Ramps Up Production
Tickers HKMPF HKMPY MCKPF MNKTQ
Tags Stories That Matter News Briefs
From Benzinga
Ascendis' Hypoparathyroidism Drug Scores FDA Approval As First and Only Treatment, Replacing Takeda's Drug Discontinued Due To Supply Issues
Tickers ASND NEWS TAK
Tags General Movers why it's moving
From Benzinga
Why Is Japanese Drugmaker Takeda Pharmaceutical Stock Trading Higher On Wednesday?
Tickers NEWS TAK
Tags TAK Trading Ideas Benzinga
From Benzinga
TAK Stock Earnings: Takeda Pharmaceutical Reported Results for Q1 2024
Tickers TAK
Tags TAK NYSE:TAK Earnings Reports
From InvestorPlace
3 Biotech Stocks to Buy on the Dip: July 2024
Tickers JAZZ PCRX TAK
Tags TAK JAZZ Market News
From InvestorPlace
Newly-Listed Psoriasis-Focused Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation
Tickers ALMS BMY JNJ NEWS
Tags Initiation Analyst Color Expert Ideas
From Benzinga
Eli Lilly's $3.2B Morphic Deal Is 'Crucial,' Has 'Strategic Merit' Despite Investor Attention On Obesity: Analyst
Tickers LLY MORF NEWS TAK
Tags Analyst Ratings Market News TAK
From Benzinga
Blackstone Nears $2.2B Deal For Sale Of Japanese Supplement Maker Alinamin: Report
Tickers BX LBO NEWS PSP
Tags Briefs BX News
From Benzinga
NextEra Energy, Lennar And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Tickers BTDR LEN NEE NEWS
Tags LEN big losers VRE
From Benzinga
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Tickers AAN AGRI ALLG AMCX
Tags LPX XTLB Gainers
From Benzinga
What's Going On With Ovid Therapeutics After Takeda's Two Phase 3 Epilepsy Studies Fail?
Tickers NEWS OVID TAK
Tags Trading Ideas TAK Benzinga
From Benzinga
Japan Pharma Giant Takeda's Anti-Seizure Treatment Flunks In Two Late-Stage Studies
Tickers NEWS TAK
Tags Market News Benzinga TAK
From Benzinga
7 F-Rated Stocks to Avoid at All Costs in June
Tickers AKTS BSFC HLTH LCID
Tags HLTH TSLA AKTS
From InvestorPlace
Blackstone Weighs Sale Of Japanese Pharma Firm Alinamin: Report
Tickers BX EQBBF NEWS TAK
Tags EQBBF Equities News
From Benzinga
Google DeepMind CEO: ‘This Is the Next $100 Billion AI Business’
Tickers AZN CRBP JANX MSFT
Tags JANX SKYE SNY
From InvestorPlace
Takeda's Dengue Vaccine Gets WHO Approval, Eligible for UN Procurement
Tickers NEWS SNY TAK
Tags SNY News Briefs
From Benzinga
Why Is Small-Cap Alzheimer's-Focused AC Immune Stock Trading Higher On Monday?
Tickers ACIU NEWS TAK
Tags General why it's moving News
From Benzinga
Why Is AC Immune (ACIU) Stock Up 45% Today?
Tickers ACIU TAK TVGN
Tags TVGN Today's Market NASDAQ:ACIU,NYSE:TAK,NASDAQ:TVGN
From InvestorPlace
Japan's Takeda Pharma Outlines $900M Overhaul To Boost Growth, As 2023 Profit Fall Over 50%
Tickers NEWS TAK
Tags General why it's moving News
From Benzinga
TAK Stock Earnings: Takeda Pharmaceutical Reported Results for Q4 2023
Tickers TAK
Tags TAK Earnings Reports NYSE:TAK
From InvestorPlace
Neurocrine Biosciences Says Treatment Can Alleviate Several Symptoms Associated With Depressive Disorder
Tickers NBIX NEWS TAK
Tags Stories That Matter Movers News
From Benzinga
The Hot List: 3 AI Stocks Worth Buying on Weakness
Tickers ABBV AI BMY BSX
Tags ICAD SDGR TMUS
From InvestorPlace
FDA Approves Takeda's Eohilia As First Oral Treatment For Inflammed Esophagus
Tickers NEWS TAK
Tags Health Care Large Cap Biotech
From Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.